최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Asian Pacific journal of tropical medicine, v.9 no.1, 2016년, pp.1 - 7
Chiow, K.H. , Phoon, M.C. , Putti, T. , Tan, B.K.H. , Chow, V.T.
Objective: To evaluate the in vitro activities of the ethyl acetate (EA) fraction of Houttuynia cordata (H. cordata) Thunb. (Saururaceae) and three of its constituent flavonoids (quercetin, quercitrin and rutin) against murine coronavirus and dengue virus (DENV). Methods: The antiviral activities of...
1 Guan Y. Zheng B.J. He Y.Q. Liu X.L. Zhuang Z.X. Cheung C.L. Isolation and characterization of viruses related to the SARS coronavirus from animals in Southern China Science 302 2003 276 278 12958366
2 Li W. Shi Z. Yu M. Ren W. Smith C. Epstein J.H. Bats are natural reservoirs of SARS-like coronaviruses Science 310 2005 676 679 16195424
3 Lau S.K. Woo P.C. Li K.S. Huang Y. Tsoi H.W. Wong B.H. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats Proc Natl Acad Sci U S A 102 2005 14040 14045 16169905
4 Chow V.T. Chan Y.C. Yong R. Lee K.M. Lim L.K. Chung Y.K. Monitoring of dengue viruses in field-caught Aedes aegypti and Aedes albopictus mosquitoes by a type-specific polymerase chain reaction and cycle sequencing Am J Trop Med Hyg 58 1998 578 586 9598444
5 Halstead S.B. Pathogenesis of dengue. Challenge to molecular biology Science 239 1988 476 481 3277268
6 Rico-Hesse R. Harrison L. Nisalak A. Vaughn D.W. Kalayanarooj S. Green S. Molecular evolution of dengue type 2 virus in Thailand Am J Trop Med Hyg 58 1998 96 101 9452299
7 Vaughn D.W. Green S. Kalayanarooj S. Innis B.L. Nimmannitya S. Suntayakorn S. Dengue viremia titer, antibody response pattern, and virus serotype correlate with severity J?Infect Dis 181 2000 2 9 10608744
8 Hayashi K. Kamiya M. Hayashi T. Virucidal effects of the steam distillate from Houttuynia cordata and its components on HSV-1, influenza virus, and HIV Planta Med 61 1995 237 241 7617766
9 Chou S.C. Su C.R. Ku Y.C. Wu T.S. The constituents and their bioactivities of Houttuynia cordata Chem Pharm Bull 57 2009 1227 1230 19881272
10 Chen X. Wang Z. Yang Z. Wang J. Xu Y. Tan R.X. Houttuynia cordata blocks HSV infection through inhibition of NF-κB activation Antiviral Res 92 2011 341 345 21951655
11 Kumar M. Prasad S.K. Hemalatha S. A?current update on the phytopharmacological aspects of Houttuynia cordata Thunb Pharmacogn Rev 8 2014 22 35 24600193
12 Hung P.Y. Ho B.C. Lee S.Y. Chang S.Y. Kao C.L. Lee S.S. Houttuynia cordata targets the beginning stage of herpes simplex virus infection PLoS One 10 2015 e0115475 25643242
13 Xie M.L. Phoon M.C. Dong S.X. Tan B.K.H. Chow V.T. Houttuynia cordata extracts and constituents inhibit the infectivity of dengue virus type 2 in?vitro Int J Integr Biol 14 2013 78 85
14 Meng J. Leung K.S. Jiang Z. Dong X. Zhao Z. Xu L.J. Establishment of HPLC-DAD-MS fingerprint of fresh Houttuynia cordata Chem Pharm Bull 53 2005 1604 1609 16327201
15 Havsteen B. Flavonoids, a class of natural products of high pharmacological potency Biochem Pharmacol 32 1983 1141 1148 6342623
16 Sanchez I. Gomez-Garibay F. Taboada J. Ruiz B.H. Antiviral effect of flavonoids on the dengue virus Phytother Res 14 2000 89 92 10685103
17 Song J.M. Lee K.H. Seong B.L. Antiviral effect of catechins in green tea on influenza virus Antiviral Res 68 2005 66 74 16137775
18 Chow V.T. Lim C.S. Phoon M.C. Tan H.C. A?seroprevalence survey of dengue virus infection in healthy Singapore university undergraduates by enzyme immunoassay and plaque reduction neutralization test Dengue Bull 29 2005 97 105
19 Lim C.S. Chua J.J. Wilkerson J. Chow V.T. Differential dengue cross-reactive and neutralizing antibody responses in BALB/c and Swiss albino mice induced by immunization with flaviviral vaccines and by infection with homotypic dengue-2 virus strains Viral Immunol 19 2006 33 41 16553548
20 Trirawatanapong T. Chandran B. Putnak R. Padmanabhan R. Mapping of a region of dengue virus type-2 glycoprotein required for binding by a neutralizing monoclonal antibody Gene 116 1992 139 150 1634111
21 Wleklik M. Luczak M. Panasiak W. Kobus M. Lammer-Zarawska E. Structural basis for antiviral activity of flavonoids-naturally occurring compounds Acta Virol 32 1988 522 525 2906224
22 Dubber M.J. Kanfer I. High-performance liquid chromatographic determination of selected flavonols in Ginkgo biloba solid oral dosage forms J?Pharm Pharm Sci 7 2004 303 309 15576009
23 Kaul T.N. Middleton E. Ogra P.L. Antiviral effect of flavonoids on human viruses J?Med Virol 15 1985 71 79 2981979
24 Vrijsen R. Everaert L. Boeye A. Antiviral activity of flavones and potentiation by ascorbate J?Gen Virol 69 1988 1749 1751 2839607
25 Vlietinck A.J. Vanden Berghe D.A. Haemers A. Present status and prospects of flavonoids as anti-viral agents Prog Clin Biol Res 280 1988 283 299 3051028
26 Choi H.J. Kim J.H. Lee C.H. Ahn Y.J. Song J.H. Baek S.H. Antiviral activity of quercetin 7-rhamnoside against porcine epidemic diarrhea virus Antiviral Res 81 2009 77 81 18992773
27 Wu C.P. Calcagno A.M. Hladky S.B. Ambudkar S.V. Barrand M.A. Modulatory effects of plant phenols on human multidrug-resistance proteins 1, 4 and 5 (ABCC1, 4 and 5) FEBS J 272 2005 4725 4740 16156793
28 Choi H.J. Song J.H. Park K.S. Kwon D.H. Inhibitory effects of quercetin 3-rhamnoside on influenza A virus replication Eur J Pharm Sci 37 2009 329 333 19491023
29 de Sousa L.R. Wu H. Nebo L. Fernandes J.B. da Silva M.F. Kiefer W. Flavonoids as noncompetitive inhibitors of dengue virus NS2B-NS3 protease: inhibition kinetics and docking studies Bioorg Med Chem 23 2015 466 470 25564380
30 Mucsi I. Combined antiviral effects of flavonoids and 5-ethyl-2′-deoxyuridine on the multiplication of herpesviruses Acta Virol 28 1984 395 400 6151353
31 Lamien C.E. Meda A. Mans J. Romito M. Nacoulma O.G. Viljoen G.J. Inhibition of fowlpox virus by an aqueous acetone extract from galls of Guiera senegalensis J. F. Gmel (Combretaceae) J?Ethnopharmacol 96 2005 249 253 15588677
32 Yang Q. Chen L. He X. Gao Z. Shen X. Bai D. Design and synthesis of cinanserin analogs as severe acute respiratory syndrome coronavirus 3CL protease inhibitors Chem Pharm Bull 56 2008 1400 1405 18827378
33 Nguyen T.T. Woo H.J. Kang H.K. Nguyen V.D. Kim Y.M. Kim D.W. Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris Biotechnol Lett 34 2012 831 838 22350287
34 Neuman B.W. Chamberlain P. Bowden F. Joseph J. Atlas of coronavirus replicase structure Virus Res 194 2014 49 66 24355834
35 Tian L. Shi X. Yu L. Zhu J. Ma R. Yang X. Chemical composition and hepatoprotective effects of polyphenol-rich extract from Houttuynia cordata tea J?Agric Food Chem 60 2012 4641 4648 22515645
36 Lau K.M. Lee K.M. Koon C.M. Cheung C.S. Lau C.P. Ho H.M. Immunomodulatory and anti-SARS activities of Houttuynia cordata J?Ethnopharmacol 118 2008 79 85 18479853
37 Yin J. Li G. Li J. Yang Q. Ren X. In?vitro and in?vivo effects of Houttuynia cordata on infectious bronchitis virus Avian Pathol 40 2011 491 498 21848486
38 Leardkamolkarn V. Sirigulpanit W. Phurimsak C. Kumkate S. Himakoun L. Sripanidkulchai B. The inhibitory actions of Houttuynia cordata aqueous extract on dengue virus and dengue-infected cell J?Food Biochem 36 2012 86 92
39 Sutton T.C. Subbarao K. Development of animal models against emerging coronaviruses: from SARS to MERS coronavirus Virology 479?480C 2015 247 258
40 Fu J. Dai L. Lin Z. Lu H. Houttuynia cordata Thunb: a review of phytochemistry and pharmacology and quality control Chin Med 4 2013 101 123
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
저자가 APC(Article Processing Charge)를 지불한 논문에 한하여 자유로운 이용이 가능한, hybrid 저널에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.